Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,360 | 57,782 | 61,813 | 20,440 | 22,489 |
| Receivables | 1,920 | 2,096 | 1,354 | 1,698 | 2,277 |
| Other current assets | 0 | 0 | 0 | 407 | 0 |
| TOTAL | $55,280 | $59,878 | $63,167 | $22,545 | $24,766 |
| Non-Current Assets | |||||
| PPE Net | 5,914 | 5,404 | 4,506 | 3,763 | 3,248 |
| Other Non-Current Assets | 626 | 544 | 464 | 402 | 346 |
| TOTAL | $6,540 | $5,948 | $4,970 | $4,165 | $3,594 |
| Total Assets | $61,820 | $65,826 | $68,137 | $26,710 | $28,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,340 | 4,205 | 3,762 | 3,613 | 2,699 |
| TOTAL | $4,340 | $4,205 | $3,762 | $3,613 | $2,699 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 967 | 872 | 690 | 629 | 563 |
| TOTAL | $967 | $872 | $690 | $629 | $563 |
| Total Liabilities | $5,307 | $5,077 | $4,452 | $4,242 | $3,262 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,593 | 7,588 | 7,586 | 7,569 | 6,567 |
| Common Shares | 76 | 76 | 76 | 66 | 66 |
| Retained earnings | -52,335 | -48,106 | -52,596 | -37,862 | -33,116 |
| TOTAL | $56,513 | $60,749 | $63,685 | $22,468 | $25,098 |
| Total Liabilities And Equity | $61,820 | $65,826 | $68,137 | $26,710 | $28,360 |